News
AGA News
A roundup of news items of interest to residents and early-career gastroenterologists
Article
What does the REPLENISH trial reveal about E2/P4’s ability to affect VMS and sleep and appropriate dosing for smokers?
Compared with placebo, women taking E2/P4 experienced reduced VMS frequency and severity and improved sleep
The REPLENISH...
Article
Postmenopausal women would benefit from clinician-initiated discussion of GSM symptoms
Almost 20% of postmenopausal women wished that their practitioner had addressed their vulvovaginal health in a discussion at...
News
Agitation in psychosis: Still no ‘magic bullet’
SAN DIEGO – Some evidence supports various treatments, including antipsychotics, Dr. Marc Agronin said.
News
PJP prophylaxis may be unnecessary for CLL patients on BTK inhibitors
EDINBURGH – The findings show an overall low pneumocystis jiroveci pneumonia prevalence in patients not receiving prophylaxis.
Article
The Health Impacts of Comorbid PTSD and MDD
Researchers dive into recent literature of how one’s health can be effected by PTSD and major depressive disorder, and find multiple areas are at...
News
5-year outcomes similar between PCI and CABG for left main CAD
SAN FRANCISCO – A 10-year or longer follow-up is required to characterize the very late safety profile of PCI and CABG.
News
FDA approves transdermal asenapine system for schizophrenia
This approval marks the first transdermal patch formulation of an antipsychotic for treatment of schizophrenia.
News
Schizophrenia patients have ‘aberrant’ response to Epstein-Barr
Individuals with schizophrenia appear to express atypical proportions of antibodies to the virus.
News
In methamphetamine use disorder, consider off-label drugs
SAN DIEGO – No approved treatments exist, but medications for other conditions might help, said Dr. Larissa J. Mooney.